Antibody Therapeutics for Life

Notices

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to attend to JP Morgan's Korea Conference 2019 (February 21-22).
  • 글쓴이 관리자
  • 작성일 2019-02-07 09:28:25
  • 조회수 531
 PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to attend to JP Morgan's Korea Conference 2019 (February 21-22).
목록





이전글 PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. ...
다음글 PharmAbcine, a clinical stage immune-oncology company, today announced that Dr....